KIMSKrishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences to buy 51% of Sarvottam Health Care

Mergers & acquisitions
Healthcare

Blacklitt Research29 October 20262 min read

A long institutional corridor with cream walls, red stripes, doors on both sides and ceiling lights. — W.carter, via Wikimedia Commons (CC0). Illustrative image.

Krishna Institute of Medical Sciences (NSE: KIMS) has entered into definitive agreements to acquire 51% of Sarvottam Health Care Private Limited, a Kakinada hospital company, for up to ₹79.50 crore, it said in a filing on 29 Oct 2026. The consideration has been remitted, and the share transfer is expected to be completed in due course.

Key highlights

Consideration: up to ₹79.50 crore, in cash
Stake: 51.00%, or 21,72,713 equity shares of ₹10 each
Target FY26 turnover: ₹84.83 crore; PAT: ₹7.06 crore
Consideration remitted on 29 Oct 2026; share transfer in due course

The acquisition in numbers

Item	Detail
Target	Sarvottam Health Care Private Limited, Kakinada (Trust Multi Speciality Hospital)
Stake acquired	51.00% (21,72,713 equity shares of ₹10 each)
Consideration	Up to ₹79.50 crore, in cash
Board-approved maximum	Up to ₹80.00 crore for up to 51%
Valuation	BDO Valuation Advisory LLP report dated 05 Oct 2026
Operation and Management agreement	Dated 10 Sep 2026 with the target
Target beds	183 present capacity; 50 at start in 2010
Target FY26 turnover	₹84.83 crore
Target FY26 PAT and networth	₹7.06 crore PAT; ₹50.30 crore networth

The target and its hospital

Sarvottam Health Care Private Limited commenced operations in 2010 with an initial capacity of 50 beds under the brand name Trust Multi Speciality Hospital. It now has a present capacity of 183 beds in Kakinada, East Godavari district.

A G+7 hospital building was inaugurated in 2021, with a total built-up area of approximately 9847.23 square metres on company-owned land of 3001.36 square yards. The target was incorporated on 19 Apr 2011.

How the company describes the stake

The company says it provides operation and management services to the target on an arm's length basis under an agreement dated 10 Sep 2026. It also says the 51% stake is a strategic investment.

The company says the shares are priced on a valuation report issued by BDO Valuation Advisory LLP dated 05 Oct 2026, and that the consideration is in cash.

Payment and share transfer

The company has remitted the consideration towards the acquisition. The filing says the transfer of the shares in its favour is expected to be completed in due course, and it lists the shares as 21,72,713 equity shares.

What the acquisition means for Krishna Institute of Medical Sciences' shareholders

The company has paid the consideration, and the share transfer is still pending. The stake is a 51% holding in a hospital company with FY26 turnover of ₹84.83 crore and PAT of ₹7.06 crore.

The filing does not say how the acquisition will affect the company's results or revenue, or when the share transfer will be completed. No dated next step is given.

Reference: Original filing (PDF)

Sign up to continue reading

Create a free account to read the rest of this article and the analysis that follows.

Disclaimer:

The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.